HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$13.95
Day range
$13.12 - $14.28
Year range
$5.68 - $16.74
Market cap
816.50M USD
Avg Volume
805.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.26M | 0.38% |
Net income | -50.71M | -6.43% |
Net profit margin | — | — |
Earnings per share | -0.77 | -5.48% |
EBITDA | -55.18M | -0.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 377.90M | -5.28% |
Total assets | 448.37M | -27.89% |
Total liabilities | 39.64M | 25.87% |
Total equity | 408.73M | — |
Shares outstanding | 60.53M | — |
Price to book | 2.06 | — |
Return on assets | -29.63% | — |
Return on capital | -31.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -50.71M | -6.43% |
Cash from operations | -38.11M | -4.05% |
Cash from investing | 22.39M | 40.26% |
Cash from financing | 715.00K | -54.80% |
Net change in cash | -15.00M | 21.37% |
Free cash flow | -20.99M | -4.80% |
About
Founded
2016
Website
Employees
109
